Abstract
New derivatives of 1,3,4-trisubstituted pyrazole have been synthesized via different reaction routs starting with the chalcone (E)-3-[3-(4-bromophenyl)-1-ethyl-1H-pyrazol-4-yl]-1-(4-chlorophenyl)prop-2-en-1-one and dicarbonitrile 2-[[3-(4-bromophenyl)-1-ethyl-1H-pyrazol-4-yl]methylene]malononitrile derived from 3-(4-bromophenyl)-1H-pyrazole-4-carbaldehyde, and the in-vitro anti-cancer activity has been tested against various human cancer cell lines, namely: hepatocellular carcinoma HepG2, breast cancer MCF7, lung carcinoma A549, prostatic cancer PC3, and colon carcinoma HCT116. Some of the tested analogs exhibited significant activity on the target cell lines, and compound 4-[3-(4-bromophenyl)-1-ethyl-1H-pyrazol-4-yl]-1,2-dihydro-2-oxo-6-(pyridin-2-yl)pyridine-3-carbonitrile was not only the most potent among the tested compounds with IC50 = 9.130, 11.957, 9.130, 29.130, and 8.913 μM, compared with the reference standard doxorubicin (IC50 = 34.242, 20.851, 5.928, 38.024, 7.174 μM) on HepG2, MCF7, A549, PC3, and HCT116 cell lines, respectively, but also displayed no cytotoxic activity on the BJ-1 fibroblast normal human cell line. Objectively, the newly synthesized analogs can serve as a brick for the development of potent anti-cancer agents.
Graphical abstract
Similar content being viewed by others
References
Stewart BW, Wild CP (2014) World cancer report 2014. Lyon CEDEX, France
Siegel RL, Miller KD, Jemal A (2016) Ca-Cancer J Clin 66:7
Grosse S, Mathieu V, Pillard C, Massip S, Marchivie M, Jarry C, Bernard P, Kiss R, Guillaumet G (2014) Eur J Med Chem 84:718
Mok NY, Maxe S, Brenk R (2013) J Chem Inf Model 53:534
Akhtar J, Khan AA, Ali Z, Haider R, Shahar Yar M (2017) Eur J Med Chem 125:143
Küçükgüzel ŞG, Şenkardeş S (2015) Eur J Med Chem 97:786
Raffa D, Maggio B, Raimondi MV, Cascioferro S, Plescia F, Cancemi G, Daidone G (2015) Eur J Med Chem 97:732
Zhang WM, Xing M, Zhao TT, Ren YJ, Yang XH, Yang YS, Lv PC, Zhu HL (2014) RSC Adv 4:37197
Baviskar AT, Banerjee UC, Gupta M, Singh R, Kumar S, Gupta MK, Kumar S, Raut SK, Khullar M, Singh S (2013) Bioorg Med Chem 21:5782
Tao XX, Duan YT, Chen LW, Tang DJ, Yang MR, Wang PF, Xu C, Zhu HL (2016) Bioorg Med Chem Lett 26:677
Miyamoto N, Sakai N, Hirayama T, Miwa K, Oguro Y, Oki H, Okada K, Takagi T, Iwata H, Awazu Y (2013) Bioorg Med Chem 21:2333
Wen J, Bao Y, Niu Q, Yang J, Fan Y, Li J, Jing Y, Zhao L, Liu D (2016) Eur J Med Chem 109:350
Bavetsias V, Faisal A, Crumpler S, Brown N, Kosmopoulou M, Joshi A, Atrash B, Pérez-Fuertes Y, Schmitt JA, Boxall KJ (2013) J Med Chem 56:9122
Kamal A, Shaik AB, Jain N, Kishor C, Nagabhushana A, Supriya B, Kumar GB, Chourasiya SS, Suresh Y, Mishra RK (2015) Eur J Med Chem 92:501
Reddy GL, Guru SK, Srinivas M, Pathania AS, Mahajan P, Nargotra A, Bhushan S, Vishwakarma RA, Sawant SD (2014) Eur J Med Chem 80:201
Wang SF, Zhu YL, Zhu PT, Makawana JA, Zhang YL, Zhao MY, Lv PC, Zhu HL (2014) Bioorg Med Chem 22:6201
Zhao MY, Yin Y, Yu XW, Sangani CB, Wang SF, Lu AM, Yang LF, Lv PC, Jiang MG, Zhu HL (2015) Bioorg Med Chem 23:46
Sun J, Lv XH, Qiu HY, Wang YT, Du QR, Li DD, Yang YH, Zhu HL (2013) Eur J Med Chem 68:1
Staben ST, Heffron TP, Sutherlin DP, Bhat SR, Castanedo GM, Chuckowree IS, Dotson J, Folkes AJ, Friedman LS, Lee L (2010) Bioorg Med Chem Lett 20:6048
Wan H, Schroeder GM, Hart AC, Inghrim J, Grebinski J, Tokarski JS, Lorenzi MV, You D, Mcdevitt T, Penhallow B (2015) ACS Med Chem Lett 6:850
Tu CH, Lin WH, Peng YH, Hsu T, Wu JS, Chang CY, Lu CT, Lyu PC, Shih C, Jiaang WT (2016) J Med Chem 59:3906
Hansen JD, Grina J, Newhouse B, Welch M, Topalov G, Littman N, Callejo M, Gloor S, Martinson M, Laird E (2008) Bioorg Med Chem Lett 18:4692
Fahmy HH, Srour AM, Ismail MA, Khater MA, Serrya RA, El-Manawaty MA (2016) Res Chem Intermed 42:6881
Recio R, Vengut-Climent E, Mouillac B, Orcel H, Lopez-Lazaro M, Calderón-Montaño JM, Alvarez E, Khiar N, Fernández I (2017) Eur J Med Chem 138:644
Ghorab MM, Alsaid MS, Al-Ansary GH, Abdel-Latif GA, El Ella DAA (2016) Eur J Med Chem 124:946
Ghorab MM, Ragab FA, Hamed MM (2009) Eur J Med Chem 44:4211
Sharma N, Brahmachari G, Banerjee B, Kant R, Gupta VK (2014) Acta Crystallogr Sect E Struct Rep Online 70:o795
Bassem S, Fayad W, Khaled M, Hallouty S, Manawaty M, Olofsson M, Linder S (2010) Ind J Exp Biol 48:258
Boyd MR, Paull KD (1995) Drug Dev Res 34:91
Grever MR, Schepartz SA, Chabner BA (1992) The National Cancer Institute: cancer drug discovery and development program. In: Seminars in oncology. WB Saunders Co, Philadelphia
Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A (1991) J Natl Cancer Inst 83:757
Thabrew M, Hughes RD, Mcfarlane IG (1997) J Pharm Pharmacol 49:1132
Mosmann T (1983) J Immunol Methods 65:55
Hooft RWW (1998) Collect, Nonius KappaCCD Data Collection Software, Nonius BV, Delft (The Netherlands)
Sheldrick G (2014) SADABS (version 2014/4). Bruker AXS Inc, Madison
Sheldrick GM (2008) Acta Crystallogr Sect A Fundam Crystallogr 64:112
Betteridge PW, Carruthers JR, Cooper RI, Prout K, Watkin DJ (2003) J Appl Crystallogr 36:1487
Cooper RI, Thompson AL, Watkin DJ (2010) J Appl Crystallogr 43:1100
Spek AL (2009) Acta Crystallogr Sect D Biol Crystallogr 65:148
Farrugia LJ (2012) J Appl Crystallogr 45:849
Macrae CF, Bruno IJ, Chisholm JA, Edgington PR, McCabe P, Pidcock E, Rodriguez-Monge L, Taylor R, Streek JV, Wood PA (2008) J Appl Crystallogr 41:466
George RF, Panda SS, Shalaby E-SM, Srour AM, Farag IA, Girgis AS (2016) RSC Adv 6:45434
Girgis AS, Aziz MN, Shalaby EM, Saleh DO, Asaad FM, El-Eraky WI, Farag IA (2016) J Chem Crystallogr 46:280
Girgis AS, Aziz MN, Shalaby EM, Saleh DO, Mishriky N, El-Eraky WI, Farag I (2016) Z Kristallogr Cryst Mater 231:179
Girgis AS, Mabied AF, Stawinski J, Hegazy L, George RF, Farag H, Shalaby EM, Farag IA (2015) New J Chem 39:8017
Mabied AF, Girgis AS, Shalaby ESM, George RF, El-Gendy BEDM, Baselious FN (2016) J Heterocycl Chem 53:1074
Shalaby EM, Girgis AS, Moustafa AM, ElShaabiny AM, El-Gendy BE-DM, Mabied AF, Farag IA (2014) J Mol Struct 1075:327
Acknowledgements
We are grateful to National Research Centre, Cairo, Egypt for financial support under Project No. 11010312.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Srour, A.M., Fahmy, H.H., Khater, M.A. et al. Synthesis, characterization, and cytotoxic activity of some new 1,3,4-trisubstituted pyrazoles against diverse tumor cell lines. Monatsh Chem 149, 1137–1147 (2018). https://doi.org/10.1007/s00706-018-2153-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-018-2153-7